{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/CSE/RVV",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Revive Therapeutics Ltd. (CSE: RVV) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nRevive Therapeutics Ltd. is listed on the CSE under ticker RVV. Its ISIN is not on the record, and its LEI is 967600MT7D67TXWXB884. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal) (CA). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 1 filing in the twelve months to 2026-11-06, on 1 filing day, and that filing is a newswire release. The median gap between filing days is not on the record. The latest filing is dated 2025-12-15, 326 days before the record date of 2026-11-06. The CSE median is 6.0 filings, a median cadence gap of 19.5 days and a median latency of 17.0 days. The Life Sciences sector median is 7.0 filings, a median cadence gap of 17.5 days and a median latency of 14 days.\n\n## Auditor\n\nThe auditor of record is Horizon Assurance LLP, and its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move lines. The record shows the issuer as listed, not halted.\n\n## Orderability\n\nUnder paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page, so the count is 0.\n\n## Open research\n\nNo openly published research notes were found, so the count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed for this market, and no issuer years are sealed. The live record began on 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://api.gleif.org/api/v1/lei-records/967600MT7D67TXWXB884 (identity.jurisdiction)\n- https://mcp.ca-cm-kg.ai/events/CSE/RVV (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/revive-therapeutics-ltd/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/RVV (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "CSE",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/listings/revive-therapeutics-ltd/",
    "state": "sourced",
    "value": "Horizon Assurance LLP"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/CSE/RVV",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 724,
     "median_cadence_gap_days": 19.5,
     "median_filings": 6,
     "median_latency_days": 17,
     "name": "CSE"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "newswire_release": 1
   },
   "cadence_median_gap_days": null,
   "filing_days": 1,
   "filings": 1,
   "latency_days": 326,
   "latest": [
    {
     "category": null,
     "date": "2025-12-15",
     "source": "https://www.globenewswire.com/news-release/2025/12/15/3205305/0/en/revive-therapeutics-provides-update-of-key-nerve-agent-countermeasure-study.html",
     "title": "Revive Therapeutics Provides Update of Key Nerve Agent",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2025-12-15",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/CSE/RVV",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "CSE"
   },
   "isin": {
    "market": "CA",
    "reason": "no ISIN found on issuer pages",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/967600MT7D67TXWXB884",
    "state": "sourced",
    "value": "Canada (federal) (CA)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/967600MT7D67TXWXB884",
    "state": "sourced",
    "value": "967600MT7D67TXWXB884"
   },
   "name": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Revive Therapeutics Ltd."
   },
   "sector": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "RVV"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:603ce55f04e966b63677d459b93f63d0e5143128971e9b85fed587a791462fd1",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/CSE/RVV",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:603ce55f04e966b63677d459b93f63d0e5143128971e9b85fed587a791462fd1",
 "path": "/ca/CSE/RVV",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Revive Therapeutics Ltd. is listed on the CSE under ticker RVV. Its ISIN is not on the record, and its LEI is 967600MT7D67TXWXB884. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal) (CA). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 1 filing in the twelve months to 2026-11-06, on 1 filing day, and that filing is a newswire release. The median gap between filing days is not on the record. The latest filing is dated 2025-12-15, 326 days before the record date of 2026-11-06. The CSE median is 6.0 filings, a median cadence gap of 19.5 days and a median latency of 17.0 days. The Life Sciences sector median is 7.0 filings, a median cadence gap of 17.5 days and a median latency of 14 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Horizon Assurance LLP, and its location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting, name change, domicile change or segment move lines. The record shows the issuer as listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page, so the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found, so the count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed for this market, and no issuer years are sealed. The live record began on 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://thecse.com/api/webapi/listed-companies/"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/967600MT7D67TXWXB884"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/CSE/RVV"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the auditor",
   "source": "https://thecse.com/listings/revive-therapeutics-ltd/"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/CSE/RVV"
  }
 ],
 "title": "Revive Therapeutics Ltd. (RVV) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}